Loading transcript...
Click for full transcript
Chapters & Sections (135)
▼
0:07
Dr. Abrams' Background and Expertise
0:48
Big Pharma's Impact on Healthcare
1:08
Dr. Abrams' Book and Influence
2:11
Personal Experience with Medicine
3:14
Blood Thinners and Life Expectancy
3:47
Doctors' Lack of Financial Knowledge
4:19
Vaccine Discussion and Censorship
4:49
Personal Experience with Life-Threatening Illness and Treatment
6:26
Challenging a Doctor's Recommendation
7:29
Peer Review and Data Access
9:04
Following Guidelines and Unwritten Rules
10:07
Sociological Determination of Science and Trust in Research
10:38
Book Review and Peer Review Process
11:12
Clinical Practice Guidelines and Lack of Data Analysis
11:43
Problems with Relying on Published Studies and Peer Reviews
12:15
Access to Original Data and Lack of Transparency
13:48
Questioning Establishment Credentials
14:19
Forced Research and Data Suppression
14:50
Conflict of Interest in Medical Research
15:50
Market Failure and Sham Peer Review
16:23
Editorial Influence and Pharmaceutical Control
16:56
Journal's Financial Model and Data Hiding
17:27
Impact of Reprint Sales on Journal Income
17:58
Historical Context and Liability Protection
19:32
Lobbying Efforts and Data Control
20:33
The Ownership Structure of Media Companies and Its Impact on Journalistic Integrity
21:03
Conflict of Interest in Pharmaceutical-Funded Journals
22:08
Market Failure and the Need for Regulation in Healthcare
23:41
Charles Barkley's Reaction to NFL Game on Peacock and Mainstream Media Silence
24:12
Peacock's Success and Reliance on Subscription Fees
24:42
Big Pharma Influence and Control
25:14
Concerns Over COVID-19 Vaccine Boosters and Lack of Data
27:19
Sharing a Personal Story and Risk Assessment
28:22
Lack of Data for Booster Shots
28:52
Family Members' Decisions and Vaccination Rates
29:57
Critique of Mandatory Vaccination Policies
30:28
Importance of Randomized Control Trials in Vaccine Booster Campaigns
30:59
Israel's Example and FDA's Failure to Conduct Randomized Control Trials
31:30
Limitations of Observational Data and FDA's Inaction
33:01
FDA's Failure to Insist on Randomized Control Trials and Global Implications
33:32
New Zealand's Approach to Pharmaceutical Advertising and Regulation
34:04
Pharmaceutical Industry in the US vs Other Countries
34:34
Comparison of Drug Approval and Information Provision between New Zealand and the US
35:06
Limitations of FDA's Role in Pharmaceutical Regulation
37:11
CMS's Role in Evaluating Drug Efficacy
37:41
FDA Approval and CMS Coverage of Skin Allergy Treatment
38:13
CMS's Decision to Not Cover New Alzheimer's Drug
39:48
Cost and Effectiveness of New Alzheimer's Treatment
40:21
CMS's Registry Requirement for Data Collection
40:53
Introduction to Allnet Registry and Pharmaceutical Companies
41:25
Concerns about Data Collection and Reporting
41:57
Expert Insights on Pharmaceutical Industry
43:00
Financial Industry and Stock Market
44:02
Anthony Fouchi's Statements and Dr. Francis Collins' Testimony
44:32
Dr. Collins' Shift in Stance on Lab Leak Theory and Pressure on Researchers
45:06
Office of the Inspector General Report and Gain of Function Research
46:08
Comparison to Financial Services Industry Transparency and Regulation
47:44
Moral Hazard in Pharmaceutical Industry and Data Ownership
49:17
Data Control and Profit Motive in Pharmaceutical Research
49:48
Market Failure and Government Intervention in Healthcare
51:22
Collaboration between NIH Director and Chinese Academy of Military Science
51:54
Fouchi's Involvement in Warp Speed Operation and Vaccine Development
52:24
Promotion of Vaccine after Election
52:56
Fouchi's Influence in Medical World and Harvard Experience
54:27
University as Echo Chamber, Not a Place of Learning
54:59
Forced Conformity and Silencing of Dissent
55:29
Censorship and Suppression of Alternative Views
56:00
Bias in Public Health Measures and Conflict of Interest
57:05
Academic Integrity and Conflicts of Interest
58:07
Vertex's Revolutionary Drug and Unfair Pricing
59:09
Harvard University's Conflict of Interest in Healthcare Policy
59:39
Unfair Pricing of Hepatitis C Drugs and Harvard's Board Members
1:00:09
Top 10 Most Expensive Drugs in America and Harvard's Conflict of Interest
1:01:45
Concerns about Hiring Practices and Representation in Aviation
1:02:15
Critique of Robert F. Kennedy Jr.'s Work and Methods
1:02:47
Specific Criticisms of Robert F. Kennedy Jr.'s Statements and Methods
1:03:19
Defense of Robert F. Kennedy Jr.'s Work and Critique of Opponents' Methods
1:04:22
Additional Criticisms and Defenses of Robert F. Kennedy Jr.'s Work
1:05:23
Criticism of NIH Director's Bias and Protection
1:05:53
Comparison to Financial Industry and Prospectuses
1:06:24
RFK's Family Legacy and Establishment Connection
1:06:54
Debate and Fact-Checking with RFK
1:09:02
Critique of Rogan's Debate Style and Biases
1:11:06
Fouchy's Exposed Risk and Protection by Mainstream Media
1:12:10
Pharmaceutical Industry's Influence and Hypocrisy
1:12:41
Large Fines and Off-Label Promotion
1:13:12
Personal Experience with Civil Litigation and the Department of Justice
1:14:16
FBI Investigation and Fraud Case
1:14:48
Subsidiaries Taking the Hit for Fines and Lack of Accountability
1:16:23
Initial Reaction to Disease X and Pandemic Threat
1:17:59
Concerns about Pharmaceutical Companies and Profit Motive
1:18:31
Potential Consequences for Pharmaceutical Companies and Advertising
1:19:32
Advertising and Data Transparency in Healthcare
1:20:33
Conflict of Interest in Pharmaceutical Advertising
1:21:35
US Healthcare Crisis and Expenditure
1:22:06
Trust in Health Organizations and Entities
1:23:09
Health Organization's Stance on Lifestyle Modification and Statins
1:24:15
Alternative Health Perspectives and Critique of Pharmaceutical Industry
1:25:17
Biotechnology and its Limitations in Improving Health
1:25:48
Research Funding Priorities and the Need for Lifestyle Information
1:26:51
Pharma's Control of Healthcare and Media
1:27:25
Pharma's Fear of Transparency and Accountability
1:28:58
Pharma's Influence on Research and Healthcare Policy
1:29:30
The Consequences of Pharma's Influence on American Healthcare
1:30:00
Critique of Pharmaceutical Industry and Patent Laws
1:31:34
Insulin Pricing and Pharmaceutical Industry Manipulation
1:32:05
Importance of Integrity in Sharing Information and Impacting Change
1h 41m
2h 13m⏭ 1
1h 51m⏭ 2
2h 8m⏭ 1
1h 49m⏭ 1
1h 48m
2h 16m
1h 55m⏭ 2
1h 50m
1h 34m⏭ 2
1h 52m
1h 52m
48m⏭ 1
1h 40m⏭ 3
1h 22m
1h 16m⏭ 4
31m⏭ 1
1h 50m⏭ 3
1h 0m⏭ 1
4h 6m⏭ 2
2h 15m⏭ 2
1h 1m
1h 28m⏭ 2
47m